Onitisin is primarily used in the pharmaceutical industry as an intermediate in the synthesis of anti-inflammatory and analgesic agents. It exhibits inhibitory activity against certain enzymes involved in inflammatory pathways, making it valuable in the development of drugs targeting pain and swelling. Due to its stability and reactivity profile, it is also employed in research settings for structure-activity relationship studies aimed at optimizing drug candidates. Additionally, Onitisin has shown potential in agrochemical formulations, where it contributes to the design of bioactive molecules with pest control properties.